Definition of the NANDA label
State in which the individual has a vague feeling of discomfort or threat accompanied by a vegetative response; there is a feeling of apprehension caused by the anticipation of danger. It is a signal that warns of imminent danger and allows the individual to take action to deal with the threat. The origin is often nonspecific or unknown to the individual.
Vague, uneasy feeling of discomfort or dread accompanied by an autonomic response (the source is often nonspecific or unknown to the individual); a feeling of apprehension caused by anticipation of danger. It is an alerting sign that warns of impending danger and enables the individual to take measures to deal with that threat.
• Restlessness and irritability.
• Anguish and fear.
• Apprehension and uncertainty.
• Nervousness and overexcitement.
• Painful and growing hopelessness.
• Growing concern
• Attention centered on the self.
• Feelings of inadequacy.
• Impaired attention.
• Decreased perceptual field.
• Fear of unspecified consequences.
• Decreased ability to learn.
• Awareness of physiological manifestations.
• Difficulty concentrating.
• Orient guilt towards others.
• Difficulty solving problems.
• Inhibition of thinking.
• Confusion, worry, and forgetfulness.
• Decrease in productivity.
• Control and surveillance.
• Poor eye contact.
• Constant glances at the environment.
• Strange movements (dragging feet, hands and arms).
• Verbal manifestations of concern about changes in life events).
• Tachypnea (by action of the sympathetic nervous system ).
• Urination urgency (parasympathetic).
• Increased pulse rate (sympathetic) or decreased (parasympathetic).
• Dilation of the pupils and hyperreflexia (sympathetic).
• Abdominal (parasympathetic) pain or discomfort.
• Sleep disorders (parasympathetic).
• Tingling in the extremities (parasympathetic).
• Diarrhea (parasympathetic).
• Hypertension (sympathetic) or hypotension (parasympathetic).
• Increased perspiration.
• Tension and facial redness (sympathetic).
• Lack of appetite (nice).
• Difficulty starting urination (sympathetic).
• Fatigue (parasympathetic) and weakness (sympathetic).
• Dry mouth (nice).
• Palpitations (sympathetic).
• Superficial (sympathetic) vasoconstriction.
• Muscle spasms (sympathetic).
• Nausea (parasympathetic).
• Urinary frequency (parasympathetic).
• Fainting (parasympathetic).
• Dyspnea (sympathetic).
• Shaking hands.
• Tremor (more or less generalized tremor).
• Changes or sense of danger in role performance.
• Exposure to toxins.
• Unconscious conflict over values and goals of life.
• Family and inheritance association.
• Unmet needs.
• Transmission and interpersonal contagion.
• Situational or maturing crisis.
• Threat of death and threat of change in health status.
• Threat of change or change in interaction patterns.
• Threat of change or change in the functioning of the role.
• Threat of change or change in the environment.
• Threat of change or change in economic status.
• Abuse of toxic substances.
At risk population
• Exposure to toxin
• Family history of anxiety
• Major change
• Maturational crisis
• Situational crisis
• Self-control of anxiety.
• Level of depression.
• Self esteem.
• Decreased anxiety.
• Active listening.
• Relaxation techniques.
• Enhancement of security.
• Emotional Support.
• Increase coping.
• Facilitate visits.
• Support for the main caregiver.
This diagnosis will retire from the NANDA-I Taxonomy in the 2021-2023 edition unless additional work is completed to bring it up to a level of evidence 2.1 or higher.